Smooth muscle cell cycle and proliferation. Relationship between calcium influx and sarco-endoplasmic reticulum Ca2+ATPase regulation. 1996

C Magnier-Gaubil, and J M Herbert, and R Quarck, and B Papp, and E Corvazier, and F Wuytack, and S Lévy-Tolédano, and J Enouf
Institut National de la Santé et de la Recherche Médicale Unité 348, IFR Circulation Lariboisière, Hôpital Lariboisière, 8 rue Guy Patin 75010 Paris, France.

The role of Ca2+ influx in the regulation of the sarco-endoplasmic reticulum Ca2+ATPases (SERCA) associated with intracellular Ca2+ pools was investigated during smooth muscle cell (SMC) proliferation induced by platelet-derived growth factor (PDGF). We first defined that the previously described up-regulation of the SERCA2a isoform found in vascular SMC after a 24-h stimulation with PDGF (Magnier, C. , Papp, B., Corvazier, E., Bredoux, R., Wuytack, F., Eggermont, F., Maclouf, J., and Enouf, J. (1992) J. Biol. Chem. 267, 15808-15815) was precisely associated with SMC entry into S phase as it appeared linked with [3H]thymidine incorporation. This was further confirmed by testing the effect of transforming growth factor-beta1, which inhibited both aortic SMC proliferation associated with G1 cell cycle arrest and PDGF-induced SERCA2a up-stimulation. Then, we tested the role of Ca2+ influx by using SR 33805, a new Ca2+ channel blocker, which was characterized with regard to the voltage Ca2+ channel blocker nifedipine and the capacitative entry Ca2+ blocker SKF 96365. SR 33805 was found to be the most potent inhibitor of both PDGF-induced SMC proliferation and the associated rise in intracellular Ca2+ concentration with IC50 values of 0.2 +/- 0.1 and 0.31 +/- 0. 04 microM, respectively. Finally, by examining in parallel both SERCA2a and SERCA2b isoforms, in terms of activity and expression, we could determine that PDGF-induced stimulation of total SERCA activity (detected by formation of the phosphorylated intermediate, E approximately P) and of SERCA2a expression (Western blotting) were abolished when extracellular Ca2+ entry was prevented by SR 33805. This study demonstrates that SERCA2a up-regulation is: 1) related to the G1/S transition step of cell cycle and 2) dependent on Ca2+ entry during PDGF-induced SMC proliferation.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D010982 Platelet-Derived Growth Factor Mitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication. Platelet Derived Growth Factor,Factor, Platelet-Derived Growth,Growth Factor, Platelet-Derived
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell

Related Publications

C Magnier-Gaubil, and J M Herbert, and R Quarck, and B Papp, and E Corvazier, and F Wuytack, and S Lévy-Tolédano, and J Enouf
September 2005, Circulation research,
C Magnier-Gaubil, and J M Herbert, and R Quarck, and B Papp, and E Corvazier, and F Wuytack, and S Lévy-Tolédano, and J Enouf
November 2022, American journal of physiology. Regulatory, integrative and comparative physiology,
C Magnier-Gaubil, and J M Herbert, and R Quarck, and B Papp, and E Corvazier, and F Wuytack, and S Lévy-Tolédano, and J Enouf
August 1995, British journal of pharmacology,
C Magnier-Gaubil, and J M Herbert, and R Quarck, and B Papp, and E Corvazier, and F Wuytack, and S Lévy-Tolédano, and J Enouf
August 1992, The Journal of biological chemistry,
C Magnier-Gaubil, and J M Herbert, and R Quarck, and B Papp, and E Corvazier, and F Wuytack, and S Lévy-Tolédano, and J Enouf
March 2020, Journal of medicinal chemistry,
C Magnier-Gaubil, and J M Herbert, and R Quarck, and B Papp, and E Corvazier, and F Wuytack, and S Lévy-Tolédano, and J Enouf
January 1998, Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie,
C Magnier-Gaubil, and J M Herbert, and R Quarck, and B Papp, and E Corvazier, and F Wuytack, and S Lévy-Tolédano, and J Enouf
January 2006, Biochemical and biophysical research communications,
C Magnier-Gaubil, and J M Herbert, and R Quarck, and B Papp, and E Corvazier, and F Wuytack, and S Lévy-Tolédano, and J Enouf
January 1997, The Biochemical journal,
C Magnier-Gaubil, and J M Herbert, and R Quarck, and B Papp, and E Corvazier, and F Wuytack, and S Lévy-Tolédano, and J Enouf
April 1989, The Journal of biological chemistry,
C Magnier-Gaubil, and J M Herbert, and R Quarck, and B Papp, and E Corvazier, and F Wuytack, and S Lévy-Tolédano, and J Enouf
November 2000, The Journal of experimental biology,
Copied contents to your clipboard!